AAIC Poster and Phase 3

The poster presentation at AAIC had some errors and this was exploited by the petition. We will discuss the errors at length on another post. This post however is to inform readers that SavaDx or plasma p-tau end points were not part of the phase 2b trial and are not subject to the blinding requirements.…More

Cassava and the Petition

Note: This is an opinion of one author When first looking through the citizen petition – the evening of Aug 24th, my initial reaction was amusement. Was this yet another unfounded document? Most petitions are, after all, dismissed. But reading through the details on this one slowly gave way to shock. After all, a few…More

Dr. Burns at AAIC ’21

Alzheimer’s Association International conference (AAIC) was held on July 29th – Cassava Sciences presented 9 month cognition data for the first 50 patients enrolled in their open label study. Their slide deck was presented word for word by Dr. Lindsay Burns, SVP and Lead Scientist. The company used the term encouraging and made no claims…More

Introduction & Cassava Sciences

This blog was setup to promote small cap bios in the Alzheimers and CNS spaces. Many small biotechs are forced to battle misinformation from social media scientists, wall street short sellers and pump & dump traders. This leads to attacks on the credibility of founders and scientists and causes extreme volatility in share prices. In…More